A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma
A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma
The purpose of this study is to compare the efficacy and safety of arlo-cel (BMS-986393) versus standard regimens in adult participants with Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma.
Inclusion Criteria
Exclusion Criteria
Clinical.Trials@bms.com855-907-3286
Birmingham, Alabama 35205, United States
205-934-1908
Orange, California 92868, United States
Washington D.C., District of Columbia 20007, United States
Miami, Florida 33136, United States
Shreveport, Louisiana 71103, United States
ABB, Buenos Aires F.D. C1199ABB, Argentina
5491126742365
ABB, Buenos Aires F.D. C1199ABB, Argentina
Yvoir, Namur 5530, Belgium
São Paulo, 05652-900, Brazil
Helsinki, Uusimaa 00029, Finland
Nantes, Pays de la Loire Region 44000, France
Kiel, Schleswig-Holstein 24105, Germany
Ramat Gan, Central District 5262100, Israel
972504065462
Turin, Piedmont 10126, Italy
Bologna, 40138, Italy
Udine, 33100, Italy
Shibuya-ku, Tokyo 150-8935, Japan
8133400104
Lodz, Łódź Voivodeship 93-513, Poland
Seoul, Seoul-teukbyeolsi [Seoul] 06591, South Korea
Santiago de Compostela, A Coruña [La Coruña] 15706, Spain
Salamanca, 37007, Spain
Taipei City, Taipei 106, Taiwan
88622312345663576
Ankara, 06200, Turkey (Türkiye)
310-829-5471
714-509-2290
202-444-1953
248-756-4524
000-000-0000
502-608-5503
505-272-4946
617-638-6428
646-962-6500
704-942-5953
704-942-5953
216-445-2025
412-578-4484
832-728-1403
801-213-8480
+5491153857234
+61295158031
0287385167
0731762111
+61 08 7074 3290
03 9594 4044
61385595000
0403374221
+61861523788
+004373276764411
004319102157300
003238215398
3227641800
+328142.3838
093324912
+5511953790662
+5511995470026
4032202801
6048754863
9024734642
9053879495
1-514-252-3404
+420532233551
420495834522
597372094
+420604483698
+4535452850
4521423108
4547324956
+4524775611
+35894711
+358405082842
+35823139288
33320444292
33240083271
33478864309
+33149812163
33142499472
+498941405968
+490511532-3020
4937133344500
493419713841
49-391-67-21233
+4943150022711
4930450653625
4970712989200
496221565427
+499113983050
004993120140001
306977448977
+306974359426
00306937437111
36303263397
972-50-5172304
97236974138
+390223902950
+390282247755
+390116336107
+390105553651
0432559618
+81-52-853-8738
81-47-133-1111
+81-90-2102-4734
81-90-9440-5616
81926425230
81-96-373-5156
81862949911
81-6-6774-5111
81236285316
+31243614794
+31(0)204442604
+318875555555
+4723070460
48502074194
+48509219986
+486895486
351225084000
40784219942
0040213180522
40740157774
6567722724
01091175012
82230105940
+821099333456
82-20-2258-6053
+34616869283
34871206268
34934978387
+0034948254000 0 000
0034958020013
34923291100
+46705931110
+46(0)812385880
+4646178746
+41714941157
886975680836
886223123456X63575
+886-2-28757529
903123360909-7215
01223596275
111-111-1111
447989474250
+441614463054
01912336161
07977969791